KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,395 | +35.4% | 11,879 | +26.5% | 0.00% | – |
| Q2 2023 | $84,483 | -28.9% | 9,387 | -37.9% | 0.00% | – |
| Q1 2023 | $118,867 | +69.1% | 15,123 | +45.4% | 0.00% | – |
| Q4 2022 | $70,304 | -52.8% | 10,400 | +1.6% | 0.00% | – |
| Q3 2022 | $149,000 | +41.9% | 10,238 | -3.7% | 0.00% | – |
| Q2 2022 | $105,000 | -44.4% | 10,633 | -17.3% | 0.00% | – |
| Q1 2022 | $189,000 | +1.6% | 12,852 | -8.7% | 0.00% | – |
| Q4 2021 | $186,000 | -32.1% | 14,078 | -10.4% | 0.00% | – |
| Q3 2021 | $274,000 | -5.2% | 15,708 | +29.9% | 0.00% | – |
| Q2 2021 | $289,000 | -9.7% | 12,091 | -3.1% | 0.00% | – |
| Q1 2021 | $320,000 | +57.6% | 12,475 | +16.5% | 0.00% | – |
| Q4 2020 | $203,000 | +113.7% | 10,712 | +41.0% | 0.00% | – |
| Q3 2020 | $95,000 | +15.9% | 7,596 | +12.6% | 0.00% | – |
| Q2 2020 | $82,000 | +148.5% | 6,747 | +55.6% | 0.00% | – |
| Q1 2020 | $33,000 | -59.3% | 4,336 | -5.7% | 0.00% | – |
| Q4 2019 | $81,000 | -19.8% | 4,598 | -47.5% | 0.00% | – |
| Q3 2019 | $101,000 | -50.5% | 8,757 | -5.7% | 0.00% | – |
| Q2 2019 | $204,000 | -59.8% | 9,286 | -47.8% | 0.00% | – |
| Q1 2019 | $508,000 | +16833.3% | 17,787 | +10424.9% | 0.00% | – |
| Q4 2018 | $3,000 | -99.2% | 169 | -99.0% | 0.00% | – |
| Q3 2018 | $358,000 | -12.5% | 16,187 | -67.9% | 0.00% | – |
| Q2 2018 | $409,000 | 0.0% | 50,461 | +16.7% | 0.00% | – |
| Q1 2018 | $409,000 | -50.1% | 43,245 | -48.5% | 0.00% | -100.0% |
| Q4 2017 | $819,000 | – | 84,004 | +1679980.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |